BenzingaJun 8, 12:30 PM ET▼ Negative
The article presents significant governance concerns including the Board's delayed termination of a poison pill only under external pressure, reversal of a publicized board refresh process, lack of transparency, and questions about accountability. The largest shareholder is calling for a vote of no confidence against incumbent directors, indicating serious dissatisfaction with Board conduct and decision-making.